Showing results (2491-2500 of 2,940) with videos related to
Sort By:
Pageof 294
Cancer Investigation|June 24, 2008
The expression of Bcl-XL, Bcl-XS and p27Kip1 in topotecan-induced apoptosis in hepatoblastoma HepG2 cell lineJun Zhang, Chao Cheng, Chuang-Long He, et al.Cancer Investigation|June 24, 2008
Reducing the risk of distant metastases: a better end point in adjuvant aromatase inhibitor breast cancer trials?Shou-Ching TangCancer Investigation|June 24, 2008
High levels of granzyme B expression in invasive cervical carcinoma correlates to poor response to treatmentValeska B Guzman, Ismael D C G Silva, Sylvia M F Brenna, et al.Cancer Investigation|September 14, 2007
Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma: a dose-finding studyM Reni, S Cereda, E Bonetto, et al.Cancer Investigation|September 14, 2007
Urticaria and angioedema in renal cell cancer patients treated with IL-2Theodore F Logan, Giovanni Strippoli, Macy I LevineCancer Investigation|September 21, 2007
A Phase II trial of oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX4) as first-line chemotherapy in advanced colorectal cancer: a China single-center experienceNong Xu, Wei-Jia Fang, Xiao-Chen Zhang, et al.Cancer Investigation|September 21, 2007
Effect of adenosine on the growth of human T-lymphocyte leukemia cell line MOLT-4Denisa Streitová, Lenka Weiterová, Michal Hofer, et al.Cancer Investigation|September 21, 2007
Protein and mRNA characterization in human colorectal carcinoma cell lines with different metastatic potentialsLi Liang, Lijuan Qu, Yanqing DingCancer Investigation|September 21, 2007
Docetaxel, capecitabine and carboplatin in metastatic esophagogastric cancer: a phase II studyDevon Evans, Thomas Miner, David Iannitti, et al.Cancer Investigation|January 1, 1989
Low-dose aminoglutethimide plus steroid replacement in advanced breast cancer patients resistant to conventional therapiesD Crivellari, E Galligioni, S Frustaci, et al.Pageof 294